EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Efficacy of Enzyme Replacement Therapy in Fabry Disease

F Barbey, D Hayoz, U Widmer, M Burnier

Current Medicinal Chemistry-Cardiovascular & Hematological Agents · 2004

DOI: 10.2174/1568016043356192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Medicinal Chemistry-Cardiovascular & Hematological Agents, 2004. Verfasst von F Barbey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Lausanne University Hospital, Switzerland. frederic.barbey@chuv.hospvd.ch. Hauptthemen laut MEDLINE: Enzyme Therapy. Die Arbeit wurde bisher 15-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enzyme TherapyEnzymesFabry DiseaseFemaleHumansIsoenzymesMaleRecombinant ProteinsTreatment Outcomealpha-Galactosidase

Substanzen

EnzymesIsoenzymesRecombinant Proteinsagalsidase alfaalpha-Galactosidaseagalsidase beta

Autor:innen und Institutionen

  • Division of Nephrology, Lausanne University Hospital, Switzerland. frederic.barbey@chuv.hospvd.ch

Zitieren

APA

Barbey, F., Hayoz, D., Widmer, U., & Burnier, M. (2004). Efficacy of Enzyme Replacement Therapy in Fabry Disease. Current Medicinal Chemistry-Cardiovascular & Hematological Agents. https://doi.org/10.2174/1568016043356192

Vancouver

Barbey F, Hayoz D, Widmer U, Burnier M. Efficacy of Enzyme Replacement Therapy in Fabry Disease. Current Medicinal Chemistry-Cardiovascular & Hematological Agents. 2004. doi:10.2174/1568016043356192

BibTeX
@article{Barbey2004,
  author = {Barbey, F and Hayoz, D and Widmer, U and Burnier, M},
  title = {Efficacy of Enzyme Replacement Therapy in Fabry Disease},
  journal = {Current Medicinal Chemistry-Cardiovascular & Hematological Agents},
  year = {2004},
  doi = {10.2174/1568016043356192}
}
Kostenlos starten →